In recent years, HER2 amplification has been evaluated as a potential prognostic biomarker and therapeutic target in urothelial carcinoma (UC). In this retrospective study, we aimed at exploring the prognostic role of HER2 amplification in UC, measured by chromogenic in situ hybridization (CISH).
Bacille Calmette-Guérin (BCG) is a well-established treatment for preventing or delaying tumour recurrence following high-grade nonmuscle invasive bladder cancer (NMIBC) resection. However, many patients will experience recurrence or progression during or following BCG.
Charles Ryan: Hello and welcome. I am delighted to be joined today by Wassim Abida from Memorial Sloan Kettering, where he is an assistant member of MSKCC and an Assistant Professor of Medicine at Weill Cornell Medical Center, Weill Cornell University, and a medical oncologist, and he worked on a really interesting abstract that was […]
Intermittent catheterization is the method of bladder management in patients with urinary retention caused by a neurogenic bladder. Neurogenic bladder can be caused by 1) upper motor neuron disease (for example, central nervous system lesions, including stroke, Parkinson’s disease, and multiple sclerosis [MS]); 2) spinal cord injury, including MS of the cord, and cervical and […]
Intermittent catheterization (IC) is the “gold standard” for individuals with bladder dysfunction caused by neurologic or non-neurologic causes, a significant and growing population in the United States. Intermittent catheterization is the recommended method for individuals who are unable to void or completely empty the bladder. According to the 6th International Consultation on Incontinence, IC has […]
What is an intermittent urinary catheter? Intermittent catheterization (IC) is the insertion and removal of a catheter several times a day to empty the bladder. The purpose of catheterization is to drain urine from a bladder that is not emptying adequately or from a surgically created channel that connects the bladder with the abdominal surface […]
Urethral Adverse Events | Scrotal Complications | Bladder-related Complications | Pain | Urinary Tract Infections | Causes of IC-related UTIs | Video Lecture | References Intermittent catheterization (IC) is the preferred procedure for individuals with incomplete bladder emptying from non-neurogenic or neurogenic lower urinary tract dysfunction (NLUTD). IC is now considered the gold standard for […]
Intermittent catheterization can have a significant physical and/or emotional impact on patients’ lives. Patients may be concerned about the discomfort associated with intermittent catheterization(IC), the need to maintain privacy, the fear of performing the catheterization, and the inability to find a clean and appropriate toilet or bathroom for catheterization when traveling outside their home. Clinicians need to […]
The number of catheter types and designs has increased with the advancement of new technology. This has added complexity to the catheterization process for both the nurse and the patient.
San Francisco, CA (UroToday.com) — AVEO Oncology announced that the National Comprehensive Cancer Network (NCCN) has updated its Clinical Practice Guidelines to include FOTIVDA® (tivozanib) as a recommended regimen for subsequent therapy. The subsequent therapy category follows the first-line treatment regimen recommendations for patients with clear cell histology renal cell carcinoma (ccRCC). On March 10, 2021, the U.S. Food […]
